Eli Lilly has communicated to more than 1,000 hospitals involved in the 340B drug discount program that they must submit claims data within the next five days.
Failure to comply with this request may result in the loss of significant price breaks that these hospitals rely on.
This move underscores Eli Lilly's commitment to enforcing compliance within the program, as seen in their previous actions against some hospitals for similar issues.
Updates
Update at 13:25 UTC on 2026-06-02
STAT reported Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks.
Sources: STAT
Update at 19:56 UTC on 2026-06-18
STAT reported Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
Sources: STAT